Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Dmitry V Zaretsky

4PUBLICATIONS

1CO-AUTHORS

BiomaterialsRheumatology and arthritisExperimental methods in fluid flow, heat and mass transfer

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|May 12, 2025

The Framework for an Integrative Theory of Alzheimer's Disease.

Dmitry V Zaretsky, Maria V Zaretskaia

|Aug 22, 2023

Towards the Integrative Theory of Alzheimer's Disease: Linking Molecular Mechanisms of Neurotoxicity, Beta-amyloid Biomarkers, and the Diagnosis.

Yaroslav I Molkov, Maria V Zaretskaia, Dmitry V Zaretsky

|Oct 31, 2022

Patients with Alzheimer's disease have an increased removal rate of soluble beta-amyloid-42.

Dmitry V Zaretsky, Maria V Zaretskaia, Yaroslav I Molkov

|Apr 25, 2018

Tissue oxidative metabolism can increase the difference between local temperature and arterial blood temperature by up to 1.3<sup>o</sup>C: Implications for brain, brown adipose tissue, and muscle physiology.

Dmitry V Zaretsky, Andrej A Romanovsky, Maria V Zaretskaia

Pageof 1

Frequent Collaborators

2 joint publications

Yaroslav I Molkov

Frequent Collaborators

2 joint publications

Yaroslav I Molkov

Top Related Videos

Quantitative 3D <em>In Silico</em> Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D <em>In Silico</em> Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on : Dec 26, 2016

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on : Aug 14, 2016

See more related videos

Top Related Videos

Quantitative 3D <em>In Silico</em> Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D <em>In Silico</em> Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on : Dec 26, 2016

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on : Aug 14, 2016

See more related videos